Zepbound Safety Warnings & Label: What You Need to Know

There's a reason Eli Lilly published an official safety video — here's everything it covers and what it means for your health.

Many patients start Zepbound without fully understanding the official risk summary and contraindications. The prescribing information can feel dense, highly clinical, and frankly intimidating. But these warnings exist for a very good reason, and understanding them could genuinely protect your health.

This is a plain-language, medically responsible breakdown of everything the official Zepbound label says. The goal is to demystify the fine print so you can have a more informed conversation with your doctor, know exactly what to watch for, and feel confident and secure about the healthcare choices you are making.

The Contraindications — Who Should NOT Take Zepbound

A "contraindication" is a specific medical situation or underlying condition that makes a medication potentially unsafe for you. Zepbound (tirzepatide) carries several official contraindications, and these aren't minor footnotes. They are the very first things your prescriber is supposed to review before ever writing that prescription.

Thyroid Cancer History — The Boxed Warning

The most serious warning in any prescription drug's label is called a "boxed warning" — sometimes referred to as a "black box warning." Zepbound carries one, and it is related to thyroid cancer.

Shutterstock

In animal studies, tirzepatide (the active ingredient in Zepbound) caused thyroid C-cell tumors in rats and mice. While it is not yet confirmed whether this occurs in humans, the risk is considered significant enough that Eli Lilly and the U.S. Food and Drug Administration (FDA) require the following strict guidelines:

• Do not use Zepbound if you or a close family member have ever had medullary thyroid carcinoma (MTC) — a specific, rare type of thyroid cancer.
• Do not use Zepbound if you have a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN2).

MEN2 is a rare inherited disorder that dramatically increases the risk of developing MTC. If you have MEN2, using a GLP-1 receptor agonist like Zepbound is considered unsafe based on current evidence.

What you should do: Before starting Zepbound, your doctor should ask about your personal and family history of thyroid disease. If they haven't asked — bring it up yourself to be safe.

Pancreatitis Risk

While not a strict contraindication in the same category as thyroid cancer, pancreatitis (severe inflammation of the pancreas) is listed as a serious warning in Zepbound's prescribing information. Cases of acute pancreatitis — some severe enough to require hospitalization — have been reported in patients using GLP-1 receptor agonists.

The official label advises:

• Do not start Zepbound if you have a history of pancreatitis without first discussing this extensively with your doctor.
• Discontinue Zepbound immediately if pancreatitis is suspected during treatment.

Symptoms of pancreatitis to watch for:

• Severe and persistent abdominal pain that does not go away.
• Pain that radiates from your abdomen to your back.
• Severe nausea and vomiting accompanying the pain.

If you experience these symptoms, do not wait — contact your healthcare provider or go to an emergency room immediately.

Other Contraindications

The official label also lists two other critical medical situations:

• Known Serious Hypersensitivity: Do not use Zepbound if you have a known allergy to tirzepatide or any of its inactive ingredients. Serious allergic reactions, including anaphylaxis and angioedema (severe swelling of the face, lips, or throat), have been reported.
• Pregnancy: Zepbound may cause fetal harm. Women who are pregnant or planning to become pregnant should discuss this immediately with their doctor. Eli Lilly officially recommends stopping Zepbound at least two months before a planned pregnancy.

Serious vs. Common Side Effects — What the Label Actually Says

Understanding the difference between a serious side effect and a common, manageable one helps you know when to call your doctor and when to simply ride it out.

Serious Side Effects

These are adverse effects that require prompt medical attention and may require stopping the medication entirely:

• Thyroid Tumors: As noted in the boxed warning. Report any unusual neck lump, hoarseness, trouble swallowing, or shortness of breath to your doctor immediately.
• Acute Pancreatitis: Look out for severe abdominal pain radiating to the back. Discontinue use and seek emergency care.
• Acute Gallbladder Disease: Zepbound has been associated with an increased risk of gallstones and gallbladder inflammation. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), rapid weight loss itself is a known risk factor for gallstone formation. Watch for upper right abdominal pain, fever, or jaundice (yellowing of skin or eyes).
• Hypoglycemia (Low Blood Sugar): This risk is highest when Zepbound is used in combination with insulin or an insulin secretagogue (like a sulfonylurea). Symptoms include shakiness, sweating, confusion, and a rapid heartbeat.
• Acute Kidney Injury: Severe vomiting and diarrhea from Zepbound can lead to dangerous dehydration, which stresses the kidneys. Stay well-hydrated, especially if experiencing gastrointestinal upset.
• Serious Hypersensitivity Reactions: Stop using Zepbound and seek emergency care if you notice hives, difficulty breathing, or rapid heartbeat after an injection.
• Diabetic Retinopathy Complications: Patients with Type 2 diabetes who also have diabetic retinopathy have experienced worsening of their eye condition on GLP-1 medications.
• Suicidal Behavior and Ideation: The FDA requires monitoring for suicidal thoughts across the GLP-1 class. Patients and families should monitor for depression, sudden mood changes, or suicidal thoughts.

Common Side Effects

These are the side effects most patients will encounter, particularly when first starting Zepbound or immediately following a dose increase. While generally not dangerous, they can affect your quality of life:

• Nausea (the most commonly reported side effect)
• Diarrhea or Constipation
• Vomiting
• General abdominal discomfort
• Injection site reactions (redness, swelling, or itching)
• Fatigue
• Belching or acid reflux (GERD)
• Hair loss (alopecia) — usually related to the physical stress of rapid weight loss rather than the drug toxicity itself.

Quick Management Tips for Common GI Side Effects:

• If you feel nauseous → Try eating smaller, more frequent meals rather than three large ones.
• If you experience acid reflux → Avoid lying down immediately after eating and limit highly acidic or spicy foods.
• If you are dealing with constipation → Increase your daily water intake and ensure you are consuming adequate dietary fiber.

Maryland Trim Clinic (MTC) in Laurel, MD

Navigating the safety warnings, side effects, and proper dosing of a powerful medication like Zepbound should never be a guessing game. Partnering with a dedicated medical team ensures your weight loss journey is both highly effective and stringently safe. The Maryland Trim Clinic (MTC) located in Laurel, MD, provides patients with the compassionate, medically supervised care required to utilize modern weight loss therapies responsibly.

At MTC, patient safety is the absolute priority. When you join their comprehensive medical weight loss program, their clinical experts conduct a thorough review of your health history to rule out any contraindications. If treatments like GLP-1 weight loss injections are deemed safe and appropriate for you, the clinic actively monitors your progress to mitigate side effects like nausea or muscle loss. To support your body during this transformation, MTC also offers expert nutritional counseling and coaching to help you stay hydrated, nourished, and energized. Whether you need guidance on managing medication side effects or are looking for a trusted partner in health, the professionals at MTC are equipped to provide the highest standard of care.

How to Use the Official Zepbound Risk Summary

Eli Lilly maintains an official resource page specifically for Zepbound safety information at zepbound.lilly.com/risk. Here is how to get the most out of it.

What You'll Find There

The official safety portal includes:

• The Full Prescribing Information (PI): The complete official label, including clinical trial data.
• The Medication Guide: A simplified, patient-facing version of the key safety warnings (your pharmacy is legally required to give you this).
• Instructions for Use: Step-by-step guidance on how to inject Zepbound correctly.
• Official Safety Video: A visual walkthrough of the major warnings.

How to Read the Prescribing Information Like a Patient

You do not need to read the entire PI document — it is dozens of pages long. But knowing where to look is empowering:

• Section 4 (Contraindications): Your first stop. It dictates who absolutely should not take the drug.
• Section 5 (Warnings and Precautions): Covers the serious risks in detail (thyroid tumors, pancreatitis, etc.).
• Section 6 (Adverse Reactions): Lists common side effects with clinical trial percentages, so you know how frequently they actually occur.
• Section 8 (Use in Specific Populations): Covers pregnancy, breastfeeding, and elderly patients.

Questions to Bring to Your Doctor

After reviewing the safety information, use this checklist at your next appointment:

• [ ] Do I have any personal or family history of thyroid cancer or MEN2 that makes Zepbound unsafe for me?
• [ ] Given my current medications, am I at risk for hypoglycemia? Should we adjust any doses?
• [ ] Do I have any kidney disease or gallbladder history I should mention?
• [ ] What specific symptoms should prompt me to call you versus going to the emergency room?
• [ ] How will we monitor my progress and side effects over the coming months?

The Bottom Line

Zepbound is a clinically proven, FDA-approved medication for chronic weight management, and for many patients, it produces meaningful, life-changing results. But like all powerful medications, it carries real risks that deserve your attention.

The official label isn't just legal fine print to be skipped — it is a roadmap for using this drug as safely as possible. Reading it, understanding it, and discussing it with your doctor isn't pessimistic; it is exactly what empowered, informed patient care looks like.

Frequently Asked Questions

Q: What is the most serious warning on the Zepbound label? A: The most serious warning is a boxed warning — the highest level of safety alert the FDA issues — related to thyroid C-cell tumors. Zepbound should not be used by anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).

Q: Can I take Zepbound if I've had pancreatitis in the past? A: A history of pancreatitis is a significant concern flagged in Zepbound's prescribing information. You should not start Zepbound without having a thorough conversation with your doctor about your history. If you develop symptoms of pancreatitis (severe abdominal pain radiating to the back, nausea, vomiting) while on Zepbound, stop the medication and seek emergency medical care immediately.

Q: What are the most common side effects patients experience on Zepbound? A: The most commonly reported side effects are gastrointestinal: nausea, diarrhea, vomiting, constipation, and abdominal pain. These tend to be most noticeable when first starting the medication or after a dose increase. Most patients find these improve over time. Eating smaller meals and staying hydrated can help reduce GI discomfort.

Q: Is Zepbound safe to use during pregnancy? A: No. Zepbound is not recommended during pregnancy, as the medication may cause fetal harm based on animal studies. Eli Lilly recommends that women stop taking Zepbound at least two months before a planned pregnancy.

Q: Where can I find the official Zepbound safety information? A: The official Zepbound risk summary and full prescribing information are available at zepbound.lilly.com/risk. When your pharmacy dispenses Zepbound, they are also legally required to provide you with the Medication Guide — a simplified version of the key warnings.

Q: Does Zepbound increase the risk of low blood sugar (hypoglycemia)? A: Hypoglycemia risk is primarily a concern when Zepbound is combined with insulin or insulin secretagogues such as sulfonylureas. Your doctor may need to reduce your doses of those other medications when you start Zepbound. Symptoms of hypoglycemia include shakiness, sweating, confusion, and dizziness.